CD20 epitope masking by rituximab: comment on the article by Gunnarsson et al.
Teng
Y K O
YK
Ioan-Facsinay
A
A
van Laar
Jacob M
JM
D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000494:pharmacology; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000276:immunology* / Q000494:pharmacology; D001402:B-Lymphocytes / Q000187:drug effects* / Q000276:immunology*; D000939:Epitopes / Q000276:immunology*; D006801:Humans; D066298:In Vitro Techniques; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000939:Epitopes; D000069283:Rituximab